Science
Mechanism of Action
This precision peptide operates by binding to specific Epidermal Growth Factor Receptors (EGFRs) located on the surface of skin cells, initiating a sophisticated intracellular signaling cascade. This process stimulates the growth, proliferation, healing, and differentiation of various skin cells, including keratinocytes in the corneous layer, endothelial cells, and fibroblasts. The outcome is enhanced skin self-regeneration, improved skin barrier function, suppressed inflammatory reactions, and reduced cutaneous scars, alongside increased synthesis of structural proteins (collagen, elastin) and glycosaminoglycans (hyaluronic acid), leading to improved skin tone, firmness, elasticity, and long-term moisturization.
Research
Clinical Evidence
Medium confidenceN/A
Transparency
Dusting Analysis
Specific effective concentrations (percentages) for SH-OLIGOPEPTIDE-1 SP in cosmetic formulations are not explicitly detailed in the available research. This absence of precise concentration guidance makes it challenging to establish a dusting threshold or definitively assess whether the ingredient is commonly underdosed in products.
The Formula
Formulation
Stability
As a medium-sized, polar molecule, SH-Oligopeptide-1 SP is inherently water-soluble. Due to its molecular characteristics, a specialized delivery system is likely required to ensure optimal penetration into the skin. Specific optimal pH ranges for stability and known incompatibilities are not explicitly detailed in the current research.
Safety
Safety Profile
SH-Oligopeptide-1 SP is generally considered safe for use in cosmetic products, with studies indicating rare adverse reactions such as mild redness, itching, or skin irritation for some individuals. While it is mitogenic (stimulates cell proliferation), experts agree it is not mutagenic (does not cause cancer). However, given that EGF signaling is often implicated in tumor cells and could potentially aid in the spread of existing cancerous cells, caution is advised. Individuals with current cancer, a history of excessive UV exposure, skin cancer risk factors, or conditions involving abnormal skin cell growth (e.g., psoriasis) should exercise prudence. Regulatory statuses from the Cosmetic Ingredient Review (CIR), Scientific Committee on Consumer Safety (SCCS), and US FDA are currently unavailable, and long-term risks for generalized cosmetic use remain unknown. It is not listed as an ingredient to be avoided during pregnancy or nursing based on currently available data.
Your Skin
Skin Compatibility
Our Assessment
Verdict
SH-Oligopeptide-1 SP demonstrates valuable clinical potential for enhancing skin regeneration, improving various signs of aging, and addressing specific conditions like melasma and acne, yet its widespread cosmetic application requires a nuanced approach due to the absence of precise concentration data for optimal efficacy and important safety considerations for certain high-risk individuals.
Related
Similar Ingredients
Finding similar ingredients…